Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more


  • Comment

VOL: 97, ISSUE: 14, PAGE NO: 41

Kate Watkiss

Nicki Ward

Kate Watkiss

- Multiple sclerosis (MS) is a chronic and generally progressive condition of the central nervous system;

- It affects approximately 85,000 people in the UK with a gender ratio of three women to every two men;

- It is second only to head injury as the leading cause of neurological disability in young adults;

- The peak age for diagnosis is 30, it remains high in the fourth decade of life and then starts to decline;

- The condition is rare in children (Ebers, 1998). Many people with MS will have a normal life span but the psychosocial impact of living with MS can be far-reaching for both the individual and their family;

- MS represents a significant health care problem; the annual cost of MS care in the UK is estimated at £1.2bn pounds;

- Despite recent advances with disease-modifying drugs, symptomatic management by a collaborative team of health care professionals is still the mainstay of the condition's treatment.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.